ID

17396

Description

Pemetrexed +/- Carboplatin as Second Line Treatment in NSCLC; ODM derived from: https://clinicaltrials.gov/show/NCT00786331

Link

https://clinicaltrials.gov/show/NCT00786331

Keywords

  1. 9/11/16 9/11/16 -
Uploaded on

September 11, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Advanced Non-Small Cell Lung Cancer NCT00786331

Eligibility Advanced Non-Small Cell Lung Cancer NCT00786331

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
written informed consent
Description

written informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
histologically or cytologically confirmed non-small-cell lung cancer
Description

non-small-cell lung cancer

Data type

boolean

Alias
UMLS CUI [1]
C0007131
unresectable stage iiib, stage iv and unresectable local relapse or metastatic disease, with evidence of disease progression after first line chemotherapy which should have included a platinum agent.
Description

metastatic disease

Data type

boolean

Alias
UMLS CUI [1]
C0027627
ecog performance status lower than or equal to 2
Description

ecog

Data type

boolean

Alias
UMLS CUI [1]
C1520224
adequate hematological, hepatic and renal functions
Description

hepatic and renal functions

Data type

boolean

Alias
UMLS CUI [1]
C0232805
UMLS CUI [2]
C0232741
life expectancy greater than or equal to 12 weeks
Description

life expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
prior treatment with only 1 chemotherapy regimen for the treatment of advanced disease which should have included a platinum agent
Description

chemotherapy regimen

Data type

boolean

Alias
UMLS CUI [1]
C0392920
at baseline, presence of at least one measurable target lesion as per recist criteria
Description

measurable target lesion

Data type

boolean

Alias
UMLS CUI [1]
C1513041
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior treatment with pemetrexed.
Description

pemetrexed

Data type

boolean

Alias
UMLS CUI [1]
C0210657
patients who are pregnant or lactating
Description

pregnant or lactating

Data type

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
patients with any underlying medical condition that might be aggravated by treatment or which cannot be controlled.
Description

medical condition

Data type

boolean

Alias
UMLS CUI [1]
C0012634
symptomatic brain metastases
Description

brain metastases

Data type

boolean

Alias
UMLS CUI [1]
C0220650
history of another malignancy within the past five years except basal cell carcinoma of the skin or carcinoma in situ of the cervix.
Description

malignancy

Data type

boolean

Alias
UMLS CUI [1]
C0006826
concomitant treatment with any other anticancer drug.
Description

concomitant treatment

Data type

boolean

Alias
UMLS CUI [1]
C1707479

Similar models

Eligibility Advanced Non-Small Cell Lung Cancer NCT00786331

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
written informed consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
non-small-cell lung cancer
Item
histologically or cytologically confirmed non-small-cell lung cancer
boolean
C0007131 (UMLS CUI [1])
metastatic disease
Item
unresectable stage iiib, stage iv and unresectable local relapse or metastatic disease, with evidence of disease progression after first line chemotherapy which should have included a platinum agent.
boolean
C0027627 (UMLS CUI [1])
ecog
Item
ecog performance status lower than or equal to 2
boolean
C1520224 (UMLS CUI [1])
hepatic and renal functions
Item
adequate hematological, hepatic and renal functions
boolean
C0232805 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
life expectancy
Item
life expectancy greater than or equal to 12 weeks
boolean
C0023671 (UMLS CUI [1])
chemotherapy regimen
Item
prior treatment with only 1 chemotherapy regimen for the treatment of advanced disease which should have included a platinum agent
boolean
C0392920 (UMLS CUI [1])
measurable target lesion
Item
at baseline, presence of at least one measurable target lesion as per recist criteria
boolean
C1513041 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
pemetrexed
Item
prior treatment with pemetrexed.
boolean
C0210657 (UMLS CUI [1])
pregnant or lactating
Item
patients who are pregnant or lactating
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
medical condition
Item
patients with any underlying medical condition that might be aggravated by treatment or which cannot be controlled.
boolean
C0012634 (UMLS CUI [1])
brain metastases
Item
symptomatic brain metastases
boolean
C0220650 (UMLS CUI [1])
malignancy
Item
history of another malignancy within the past five years except basal cell carcinoma of the skin or carcinoma in situ of the cervix.
boolean
C0006826 (UMLS CUI [1])
concomitant treatment
Item
concomitant treatment with any other anticancer drug.
boolean
C1707479 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial